Differences between neurofibromatosis-1-associated malignant peripheral nerve sheath tumors (MPNST) and sporadic MPNST: The Mayo Clinic experience.

被引：0
|
作者：
Johnson, K. N.
Stucky, C. H.
Pockaj, B. A.
Gray, R. J.
Rose, P. S.
Wasif, N.
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.10066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10066
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
    Brigitte C. Widemann
    Current Oncology Reports, 2009, 11 : 322 - 328
  • [32] Current Status of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
    Widemann, Brigitte C.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (04) : 322 - 328
  • [33] FOCAL ADHESION KINASE (FAK) IN CHROMOSOME 8 GAIN-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
    Wang, Guangfeng
    Borcherding, Dana
    Oztosun, Gorkem
    Zhang, Xiaochun
    Yang, Liuzhan
    Gannu, Trisha
    Hirbe, Angela
    NEURO-ONCOLOGY, 2024, 26
  • [34] Molecular Characterization of Permanent Cell Lines from Primary, Metastatic and Recurrent Malignant Peripheral Nerve Sheath Tumors (MPNST) with Underlying Neurofibromatosis-1
    Fang, Yuqiang
    Elahi, Abul
    Denley, Ryan C.
    Rao, Pulivarthi H.
    Brennan, Murray F.
    Jhanwar, Suresh C.
    ANTICANCER RESEARCH, 2009, 29 (04) : 1255 - 1262
  • [35] Sporadic malignant peripheral nerve sheath tumour (MPNST) in a 3-year-old girl: A diagnostic challenge
    Zawaw, Muhamad Syahrul Fitri
    Wan Ismail, Wan Faisham Nu'mun
    Mustapar, Nurulhasanah
    Mohamad, Norsarwany
    Nasir, Ariffin
    Tuan Sharif, Sharifah Emilia
    MALAYSIAN JOURNAL OF PATHOLOGY, 2022, 44 (01) : 115 - 120
  • [36] Malignant peripheral nerve sheath tumors in neurofibromatosis 1
    King, AA
    DeBaun, RR
    Riccardi, VM
    Gutmann, DH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 93 (05): : 388 - 392
  • [37] SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).
    Widemann, Brigitte C.
    Meyer, Christian Frederick
    Cote, Gregory Michael
    Chugh, Rashmi
    Milhem, Mohammed M.
    Van Tine, Brian Andrew
    Kim, AeRang
    Turpin, Brian
    Dombi, Eva
    Jayaprakash, Nalini
    Okuno, Scott H.
    Helman, Lee J.
    Onwudiwe, Ndidi
    Steinberg, Seth M.
    Reinke, Denise K.
    Cichowski, Karen
    Perentesis, John Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors
    Yu, Yanan
    Wei, Chengjiang
    Yue, Minghui
    Zhang, Cheng
    Wang, Yixiao
    Wang, Zhichao
    CELLULAR ONCOLOGY, 2025,
  • [39] Utility of MRI and PET/CT to differentiate benign versus malignant peripheral nerve sheath tumors (MPNST).
    Sebro, Ronnie
    Niziolek, Paul
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 63 - 63
  • [40] Malignant peripheral nerve sheath tumour (MPNST) arising in plexiform neurofibroma in a neurofibromatosis type I (NF1) patient
    Sykaras, A.
    Gioti, E.
    Stavrinou, N.
    Dolkiras, P.
    Christofidis, K.
    Kouvidou, C.
    VIRCHOWS ARCHIV, 2021, 479 : S307 - S307
12345